Who should be offered HIV pre-exposure prophylaxis (PrEP)?: A secondary analysis of a Phase 3 PrEP efficacy trial in men who have sex with men and transgender women

BACKGROUND: Pre-exposure prophylaxis (PrEP) has been proven to reduce HIV acquisition in men who have sex with men and transgender women (MSM/TGW). For maximal impact, PrEP should be targeted to subpopulations accounting for the largest proportion of infections (population attributable fraction, PAF...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Buchbinder, Susan P, Glidden, David V., Liu, Albert Y., McMahan, Vanessa, Guanira, Juan V., Mayer, Kenneth H., Goicochea, Pedro, Grant, Robert M.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4133171/
https://ncbi.nlm.nih.gov/pubmed/24613084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(14)70025-8
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky